1.52
price down icon7.88%   -0.13
after-market Handel nachbörslich: 1.59 0.07 +4.61%
loading

Finanzdaten der Lexicon Pharmaceuticals Inc-Aktie (LXRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
96.72%
0.692
21.10 5.493 14.18 28.87
Cost Of Revenue
63.89%
0.039
0.108 0.201 0.01 0.033
Selling, General, and Administrative
5.59%
9.75
9.234 - - -
Costs And Expenses
23.23%
27.23
22.10 20.27 26.37 25.13
Operating Income/Loss
2,565%
-26.54
-0.996 -14.78 -12.19 3.736
Net Income/Loss
2,947%
-31.77
-1.043 -15.53 -12.77 3.252
Basic Average Shares
9.35%
437.65
400.24 0.126 363.40 363.29
Diluted Average Shares
9.35%
437.65
400.24 0.126 363.40 363.57
Basic Earnings Per Share
-0.07
- -0.04 -0.04 0.01
Diluted Earnings Per Share
-0.07
- -0.04 -0.04 0.01
$2.27
price down icon 8.28%
$12.14
price down icon 5.67%
$4.59
price down icon 2.96%
$9.36
price down icon 2.80%
$7.98
price down icon 8.06%
DNA DNA
$10.27
price down icon 12.67%
Kapitalisierung:     |  Volumen (24h):